跳转至内容
Merck
所有图片(3)

主要文件

05-840

Sigma-Aldrich

抗IDO(吲哚胺 2,3-双加氧酶)抗体,克隆10.1

clone 10.1, Upstate®, from mouse

别名:

Indoleamine 2,3-dioxygenase, Indoleamine-pyrrole 2,3-dioxygenase, indole 2,3-dioxygenase, indoleamine-pyrrole 2,3 dioxygenase, IDO1

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

mouse

品質等級

抗體表格

purified immunoglobulin

抗體產品種類

primary antibodies

無性繁殖

10.1, monoclonal

物種活性

human, mouse

製造商/商標名

Upstate®

技術

immunocytochemistry: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable

同型

IgG

NCBI登錄號

UniProt登錄號

運輸包裝

wet ice

基因資訊

human ... IDO1(3620)
mouse ... Ido1(15930)

一般說明

吲哚胺2,3-双加氧酶(IDO)是一种负责将色氨酸转化为犬尿氨酸的酶。IDO在多种组织中表达,并且IDO可以被干扰素γ上调。IDO调节氨基酸色氨酸的水平,这对细胞生长至关重要,但也参与抑制免疫反应。IDO可能参与抑制对肿瘤的免疫反应,阻断IDO途径可能是免疫治疗的潜在靶标。

特異性

识别IDO(吲哚胺 2,3-双加氧酶),Mr 42 kDa。

免疫原

GST融合蛋白,对应人吲哚胺 2,3-双加氧酶(IDO)的78-184位残基。克隆10.1。

應用

免疫细胞化学:先前批次已被独立实验室用于表达载体转染的Phoenix细胞中。

免疫组化:该抗体的先前批次用于检测人视网膜、原发性眼肿瘤和转移性肝肿瘤组织切片中的IDO(Chen, P.W., et al. Experimental Eye Research 85(2007) 617-625)。
抗IDO(吲哚胺2,3-双加氧酶)抗体,克隆10.1是用于IC & WB的抗IDO(吲哚胺2)的抗体。

品質

已通过蛋白质印迹对未经处理和经IFNγ处理(24 hrs)的Hela裂解液进行了常规评估。

蛋白质印迹分析:
该批次的1:500稀释液在10 ug未处理和IFNγ处理的Hela裂解液中检测到IDO。

標靶描述

42 kDa

聯結

替代:04-1056

外觀

形式:纯化
纯化的小鼠单克隆IgG,溶于含有70%储存缓冲液(0.1 M Tris-甘氨酸(pH 7.4)、0.15 M NaCl、0.05%叠氮化钠)和30%甘油的缓冲液中。

分析報告

对照
人IFN-γ刺激HeLa细胞裂解物,IFNγ刺激人外周血淋巴细胞。

其他說明

浓度:请参考批次特异性浓缩物的分析证书。

法律資訊

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 1


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

M W Taylor et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 5(11), 2516-2522 (1991-08-01)
Interferons have been shown to be potential anti-cancer agents and to inhibit tumor cell growth in culture. The in vivo mechanism of the anti-proliferative effect may be direct or indirect through the immune system; however, in vitro a primary mechanism
David H Munn et al.
Science (New York, N.Y.), 297(5588), 1867-1870 (2002-09-14)
Antigen-presenting cells (APCs) can induce tolerance or immunity. We describe a subset of human APCs that express indoleamine 2,3-dioxygenase (IDO) and inhibit T cell proliferation in vitro. IDO-positive APCs constituted a discrete subset identified by coexpression of the cell-surface markers
Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity.
Takikawa, O, et al.
The Journal of Biological Chemistry, 263, 2041-2048 (1988)
Annabel Meireson et al.
Frontiers in immunology, 12, 736498-736498 (2021-09-25)
Immune escape is an early phenomenon in cancer development/progression. Indoleamine 2,3-dioxygenase 1 (IDO1) is a normal endogenous mechanism of acquired peripheral immune tolerance and may therefore be tumor-promoting. This study investigated the clinical relevance of IDO1 expression by immune cells
Ying Lu et al.
Blood, 119(4), 1075-1085 (2011-12-02)
Allogeneic hematopoietic stem cell transplantation (HSCT) can eradicate chemorefractory leukemia through the graft-versus-leukemia (GVL) activity of donor T cells. However, the clinical success of allo-HSCT is limited by the graft-versus-host disease (GVHD) activity of donor T cells. We have reported

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门